Author
Listed:
- Guangjian Fan
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University
Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine)
- Lianhui Sun
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University
Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine)
- Peipei Shan
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University
Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine)
- Xianying Zhang
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Jinliang Huan
(Shanghai Eighth People’s Hospital)
- Xiaohong Zhang
(USF Morsani College of Medicine)
- Dali Li
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Tingting Wang
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Tingting Wei
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Xiaohong Zhang
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Xiaoyang Gu
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Liangfang Yao
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Yang Xuan
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Zhaoyuan Hou
(Shanghai Jiao Tong University School of Medicine)
- Yongping Cui
(Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University)
- Liu Cao
(Key Laboratory of Medical Cell Biology, College of Translational Medicine, China Medical University)
- Xiaotao Li
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University)
- Shengping Zhang
(Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine)
- Chuangui Wang
(Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences, East China Normal University
Institute of Translational Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Key Laboratory of Medical Cell Biology, College of Translational Medicine, China Medical University)
Abstract
Centrosome amplification is frequent in cancer, but the underlying mechanisms remain unclear. Here we report that disruption of the Kruppel-like factor 14 (KLF14) gene in mice causes centrosome amplification, aneuploidy and spontaneous tumorigenesis. Molecularly, KLF14 functions as a transcriptional repressor of Plk4, a polo-like kinase whose overexpression induces centrosome overduplication. Transient knockdown of KLF14 is sufficient to induce Plk4-directed centrosome amplification. Clinically, KLF14 transcription is significantly downregulated, whereas Plk4 transcription is upregulated in multiple types of cancers, and there exists an inverse correlation between KLF14 and Plk4 protein expression in human breast and colon cancers. Moreover, KLF14 depletion promotes AOM/DSS-induced colon tumorigenesis. Our findings reveal that KLF14 reduction serves as a mechanism leading to centrosome amplification and tumorigenesis. On the other hand, forced expression of KLF14 leads to mitotic catastrophe. Collectively, our findings identify KLF14 as a tumour suppressor and highlight its potential as biomarker and therapeutic target for cancer.
Suggested Citation
Guangjian Fan & Lianhui Sun & Peipei Shan & Xianying Zhang & Jinliang Huan & Xiaohong Zhang & Dali Li & Tingting Wang & Tingting Wei & Xiaohong Zhang & Xiaoyang Gu & Liangfang Yao & Yang Xuan & Zhaoyu, 2015.
"Loss of KLF14 triggers centrosome amplification and tumorigenesis,"
Nature Communications, Nature, vol. 6(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9450
DOI: 10.1038/ncomms9450
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:6:y:2015:i:1:d:10.1038_ncomms9450. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.